{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:50:46Z","timestamp":1788299446720,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"27-28","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.vaccine.2004.03.024","type":"journal-article","created":{"date-parts":[[2004,4,15]],"date-time":"2004-04-15T09:36:44Z","timestamp":1082021804000},"page":"3669-3675","source":"Crossref","is-referenced-by-count":27,"title":["Immunogenicity and protective efficacy in mice of a formaldehyde-inactivated Indian strain of Japanese encephalitis virus grown in Vero cells"],"prefix":"10.1016","volume":"22","author":[{"given":"Mohan Babu","family":"Appaiahgari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhanshu","family":"Vrati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2004.03.024_BIB1","first-page":"625","article-title":"Japanese encephalitis: current worldwide status","volume":"63","author":"Umenai","year":"1985","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.vaccine.2004.03.024_BIB2","doi-asserted-by":"crossref","first-page":"533","DOI":"10.5694\/j.1326-5377.1999.tb127878.x","article-title":"Japanese encephalitis in north Queensland, Australia, 1998","volume":"170","author":"Hanna","year":"1999","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.vaccine.2004.03.024_BIB3","unstructured":"World Health Organization. Japanese encephalitis vaccines. Wkly Epidemiol Rec 1998;73:334\u201344."},{"key":"10.1016\/j.vaccine.2004.03.024_BIB4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4049\/jimmunol.72.4.248","article-title":"Neutralizing antibodies against certain viruses in the sera of residents of India","volume":"72","author":"Smithburn","year":"1954","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2004.03.024_BIB5","first-page":"77","article-title":"The first epidemic of Japanese encephalitis studied in India-virological studies","volume":"63","author":"Chakravarty","year":"1975","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.vaccine.2004.03.024_BIB6","first-page":"204","article-title":"An epidemic of Japanese encephalitis in Haryana in the year 1990","volume":"23","author":"Sharma","year":"1991","journal-title":"J. Commun. Dis."},{"key":"10.1016\/j.vaccine.2004.03.024_BIB7","first-page":"168","article-title":"An outbreak of Japanese encephalitis in Haryana-1990","volume":"23","author":"Sharma","year":"1991","journal-title":"J. Commun. Dis."},{"key":"10.1016\/j.vaccine.2004.03.024_BIB8","first-page":"905","article-title":"An epidemic of encephalitis in Haryana: serological evidence of Japanese encephalitis in a few patients","volume":"30","author":"Prasad","year":"1993","journal-title":"Indian Pediatr."},{"key":"10.1016\/j.vaccine.2004.03.024_BIB9","first-page":"129","article-title":"Some epidemiological characteristics of Japanese encephalitis in Haryana state of northern India","volume":"30","author":"Kar","year":"1998","journal-title":"J. Commun. Dis."},{"key":"10.1016\/j.vaccine.2004.03.024_BIB10","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0264-410X(97)00020-0","article-title":"Allergic mucocutaneous reactions to Japanese encephalitis vaccine","volume":"15","author":"Plesner","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.03.024_BIB11","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/0140-6736(91)92707-9","article-title":"Side-effects with Japanese encephalitis vaccine","volume":"337","author":"Andersen","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2004.03.024_BIB12","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0140-6736(91)91531-X","article-title":"Adverse reactions to Japanese encephalitis vaccine","volume":"338","author":"Ruff","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2004.03.024_BIB13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0264-410X(96)00170-3","article-title":"Systemic immediate-type reactions to gelatin included in Japanese encephalitis vaccines","volume":"15","author":"Sakaguchi","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.03.024_BIB14","doi-asserted-by":"crossref","first-page":"677","DOI":"10.4269\/ajtmh.1999.61.677","article-title":"Complete nucleotide sequence of an Indian strain of Japanese encephalitis virus: sequence comparison with other strains and phylogenetic analysis","volume":"61","author":"Vrati","year":"1999","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.vaccine.2004.03.024_BIB15","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4269\/ajtmh.2001.65.242","article-title":"Phylogenetic analysis of Japanese encephalitis virus: envelope gene based analysis reveals a fifth genotype, geographic clustering, and multiple introductions of the virus into the Indian subcontinent","volume":"65","author":"Uchil","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.vaccine.2004.03.024_BIB16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF02703933","article-title":"Comparison of the genome sequences and phylogenetic analyses of the GP78 and the Vellore P20778 isolates of Japanese encephalitis virus from India","volume":"25","author":"Vrati","year":"2000","journal-title":"J. Biosci."},{"key":"10.1016\/j.vaccine.2004.03.024_BIB17","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1099\/0022-1317-80-7-1665","article-title":"Molecular characterization of an Indian isolate of Japanese encephalitis virus that shows an extended lag phase during growth","volume":"80","author":"Vrati","year":"1999","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.vaccine.2004.03.024_BIB18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/338015","article-title":"Plasmid DNA immunization against Japanese Encephalitis Virus: immunogenicity of membrane-anchored and secretory envelope protein","volume":"185","author":"Kaur","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2004.03.024_BIB19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0264-410X(98)00156-X","article-title":"Protection against lethal Japanese encephalitis virus infection of mice by immunization with the highly attenuated MVA strain of vaccinia virus expressing JEV prM and E genes","volume":"17","author":"Nam","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.03.024_BIB20","first-page":"137","article-title":"Experience with vero cells at Pasteur Merieux Connaught","volume":"98","author":"Montagnon","year":"1999","journal-title":"Dev. Biol. Stand."},{"key":"10.1016\/j.vaccine.2004.03.024_BIB21","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0065-3527(03)61010-9","article-title":"Formalin-inactivated whole virus and recombinant subunit flavivirus vaccines","volume":"61","author":"Eckels","year":"2003","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.vaccine.2004.03.024_BIB22","first-page":"261","article-title":"Production of purified Japanese encephalitis vaccine from Vero cells with roller bottles","volume":"78","author":"Ding","year":"1998","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.vaccine.2004.03.024_BIB23","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1016\/S0264-410X(01)00208-0","article-title":"A purified inactivated Japanese encephalitis virus vaccine made in Vero cells","volume":"19","author":"Srivastava","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.03.024_BIB24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00277160","article-title":"Immunogenicity of a viral model vaccine after different inactivation procedures","volume":"183","author":"Bachmann","year":"1994","journal-title":"Med. Microbiol. Immunol. (Berlin)"},{"key":"10.1016\/j.vaccine.2004.03.024_BIB25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/biol.2002.0345","article-title":"Development of Vero cell-derived inactivated Japanese encephalitis vaccine","volume":"30","author":"Sugawara","year":"2002","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2004.03.024_BIB26","doi-asserted-by":"crossref","first-page":"7992","DOI":"10.1128\/JVI.72.10.7992-8001.1998","article-title":"Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins","volume":"72","author":"Rossio","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.vaccine.2004.03.024_BIB27","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/infdis\/174.6.1176","article-title":"Development of a purified, inactivated, dengue-2 virus vaccine prototype in Vero cells: immunogenicity and protection in mice and rhesus monkeys","volume":"174","author":"Putnak","year":"1996","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.vaccine.2004.03.024_BIB28","first-page":"135","article-title":"Induction of immune response and protection from equine viral arteritis (EVA) by formalin inactivated-virus vaccine for EVA in horses","volume":"37","author":"Fukunaga","year":"1990","journal-title":"Zentralbl Veterinarmed B"},{"key":"10.1016\/j.vaccine.2004.03.024_BIB29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmv.1890110102","article-title":"Inactivation of hepatitis B virus by three methods: treatment with pepsin, urea, or formalin","volume":"11","author":"Tabor","year":"1983","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.vaccine.2004.03.024_BIB30","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/00002030-199512000-00017","article-title":"Conservation of HIV-1 gp120 neutralizing epitopes after formalin-inactivation","volume":"9","author":"Sattentau","year":"1995","journal-title":"AIDS"},{"key":"10.1016\/j.vaccine.2004.03.024_BIB31","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1128\/JVI.67.7.3917-3922.1993","article-title":"Formalin-inactivation of vesicular stomatitis virus impairs T-cell- but not T-help-independent B-cell responses","volume":"67","author":"Bachmann","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.vaccine.2004.03.024_BIB32","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0264-410X(89)90275-2","article-title":"Effects of formalin-inactivation on bovine herpes virus-1 glycoproteins and antibody response elicited by formalin-inactivated vaccines in rabbits","volume":"7","author":"Duque","year":"1989","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.03.024_BIB33","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1128\/JVI.62.9.3210-3216.1988","article-title":"Formalin-inactivation of the lactate dehydrogenase-elevating virus reveals a major neutralizing epitope not recognized during natural infection","volume":"62","author":"Harty","year":"1988","journal-title":"J. Virol."},{"key":"10.1016\/j.vaccine.2004.03.024_BIB34","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0264-410X(85)90077-5","article-title":"Antigenic relationships between an isolate of the western subtype of tick-borne encephalitis virus and an inactivated vaccine derived from it","volume":"3","author":"Lee","year":"1985","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2004.03.024_BIB35","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1128\/JVI.73.7.5527-5534.1999","article-title":"The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus premembrane and envelope genes","volume":"73","author":"Konishi","year":"1999","journal-title":"J. Virol."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04002646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X04002646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T08:01:39Z","timestamp":1682668899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X04002646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":35,"journal-issue":{"issue":"27-28","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0264410X04002646"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2004.03.024","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}